Ignite Creation Date:
2025-12-24 @ 3:32 PM
Ignite Modification Date:
2026-02-02 @ 1:07 PM
Study NCT ID:
NCT02201992
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-19
First Post:
2014-07-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Sponsor:
ECOG-ACRIN Cancer Research Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-03-23
Start Date Type:
ACTUAL
Primary Completion Date:
2036-05-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2036-05-01
Completion Date Type:
ESTIMATED
First Submit Date:
2014-07-21
First Submit QC Date:
None
Study First Post Date:
2014-07-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-17
Last Update Post Date:
2025-12-19
Last Update Post Date Type:
ESTIMATED